Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from TrivarX Limited ( (AU:TRI) ).
TrivarX Limited has disclosed a significant increase in director Christopher Ntoumenopoulos’s equity exposure following shareholder-approved capital raisings and incentive issuances. The director, through direct holdings and indirectly via Sobol Capital Pty Ltd, has acquired 11.25 million new ordinary shares and 75 million long-dated options as part of a placement and as facilitation fees for services linked to TrivarX’s acquisition of Nucleics, materially lifting his stake and aligning his interests more closely with the company’s future performance.
More about TrivarX Limited
YTD Price Performance: 6.25%
Average Trading Volume: 3,115,487
Technical Sentiment Signal: Sell
Current Market Cap: A$12.17M
See more insights into TRI stock on TipRanks’ Stock Analysis page.